The global Smart Pills and Drugs Delivery System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Smart Pills and Drugs Delivery System refers to an intelligent drug delivery system that helps doctors and patients better manage the drug treatment process. Such systems typically consist of a smart drug (smart capsule) and a device that can help doctors and patients better understand how the drug is absorbed and how it works.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淪mart Pills and Drugs Delivery System Industry Forecast鈥� looks at past sales and reviews total world Smart Pills and Drugs Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected Smart Pills and Drugs Delivery System sales for 2025 through 2031. With Smart Pills and Drugs Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Smart Pills and Drugs Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Smart Pills and Drugs Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Smart Pills and Drugs Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Smart Pills and Drugs Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Smart Pills and Drugs Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Smart Pills and Drugs Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Smart Pills and Drugs Delivery System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Wearable Injector
Auto Injector
Pen Injector
Others
Segmentation by Application:
Clinic
Hospital
Home Care
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BD
Abbott
HCmed Innovations
Adherium
BIOCORP
Medtronic
Novartis AG
Novo Nordisk A/S
Amiko Digital Health
Boston Scientific Corporation
CeQur Simplicity
Microchip Technology
FUJIFILM Holdings Corporation
E3D Elcam Drug Delivery Devices
Koninklijke Philips N.V
H&T Presspart Manufacturing
Key Questions Addressed in this Report
What is the 10-year outlook for the global Smart Pills and Drugs Delivery System market?
What factors are driving Smart Pills and Drugs Delivery System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Smart Pills and Drugs Delivery System market opportunities vary by end market size?
How does Smart Pills and Drugs Delivery System break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Smart Pills and Drugs Delivery System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Smart Pills and Drugs Delivery System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Smart Pills and Drugs Delivery System by Country/Region, 2020, 2024 & 2031
2.2 Smart Pills and Drugs Delivery System Segment by Type
2.2.1 Wearable Injector
2.2.2 Auto Injector
2.2.3 Pen Injector
2.2.4 Others
2.3 Smart Pills and Drugs Delivery System Sales by Type
2.3.1 Global Smart Pills and Drugs Delivery System Sales Market Share by Type (2020-2025)
2.3.2 Global Smart Pills and Drugs Delivery System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Smart Pills and Drugs Delivery System Sale Price by Type (2020-2025)
2.4 Smart Pills and Drugs Delivery System Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Home Care
2.4.4 Others
2.5 Smart Pills and Drugs Delivery System Sales by Application
2.5.1 Global Smart Pills and Drugs Delivery System Sale Market Share by Application (2020-2025)
2.5.2 Global Smart Pills and Drugs Delivery System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Smart Pills and Drugs Delivery System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Smart Pills and Drugs Delivery System Breakdown Data by Company
3.1.1 Global Smart Pills and Drugs Delivery System Annual Sales by Company (2020-2025)
3.1.2 Global Smart Pills and Drugs Delivery System Sales Market Share by Company (2020-2025)
3.2 Global Smart Pills and Drugs Delivery System Annual Revenue by Company (2020-2025)
3.2.1 Global Smart Pills and Drugs Delivery System Revenue by Company (2020-2025)
3.2.2 Global Smart Pills and Drugs Delivery System Revenue Market Share by Company (2020-2025)
3.3 Global Smart Pills and Drugs Delivery System Sale Price by Company
3.4 Key Manufacturers Smart Pills and Drugs Delivery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Smart Pills and Drugs Delivery System Product Location Distribution
3.4.2 Players Smart Pills and Drugs Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Smart Pills and Drugs Delivery System by Geographic Region
4.1 World Historic Smart Pills and Drugs Delivery System Market Size by Geographic Region (2020-2025)
4.1.1 Global Smart Pills and Drugs Delivery System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Smart Pills and Drugs Delivery System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Smart Pills and Drugs Delivery System Market Size by Country/Region (2020-2025)
4.2.1 Global Smart Pills and Drugs Delivery System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Smart Pills and Drugs Delivery System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Smart Pills and Drugs Delivery System Sales Growth
4.4 APAC Smart Pills and Drugs Delivery System Sales Growth
4.5 Europe Smart Pills and Drugs Delivery System Sales Growth
4.6 Middle East & Africa Smart Pills and Drugs Delivery System Sales Growth
5 Americas
5.1 Americas Smart Pills and Drugs Delivery System Sales by Country
5.1.1 Americas Smart Pills and Drugs Delivery System Sales by Country (2020-2025)
5.1.2 Americas Smart Pills and Drugs Delivery System Revenue by Country (2020-2025)
5.2 Americas Smart Pills and Drugs Delivery System Sales by Type (2020-2025)
5.3 Americas Smart Pills and Drugs Delivery System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Smart Pills and Drugs Delivery System Sales by Region
6.1.1 APAC Smart Pills and Drugs Delivery System Sales by Region (2020-2025)
6.1.2 APAC Smart Pills and Drugs Delivery System Revenue by Region (2020-2025)
6.2 APAC Smart Pills and Drugs Delivery System Sales by Type (2020-2025)
6.3 APAC Smart Pills and Drugs Delivery System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Smart Pills and Drugs Delivery System by Country
7.1.1 Europe Smart Pills and Drugs Delivery System Sales by Country (2020-2025)
7.1.2 Europe Smart Pills and Drugs Delivery System Revenue by Country (2020-2025)
7.2 Europe Smart Pills and Drugs Delivery System Sales by Type (2020-2025)
7.3 Europe Smart Pills and Drugs Delivery System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Smart Pills and Drugs Delivery System by Country
8.1.1 Middle East & Africa Smart Pills and Drugs Delivery System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Smart Pills and Drugs Delivery System Revenue by Country (2020-2025)
8.2 Middle East & Africa Smart Pills and Drugs Delivery System Sales by Type (2020-2025)
8.3 Middle East & Africa Smart Pills and Drugs Delivery System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Smart Pills and Drugs Delivery System
10.3 Manufacturing Process Analysis of Smart Pills and Drugs Delivery System
10.4 Industry Chain Structure of Smart Pills and Drugs Delivery System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Smart Pills and Drugs Delivery System Distributors
11.3 Smart Pills and Drugs Delivery System Customer
12 World Forecast Review for Smart Pills and Drugs Delivery System by Geographic Region
12.1 Global Smart Pills and Drugs Delivery System Market Size Forecast by Region
12.1.1 Global Smart Pills and Drugs Delivery System Forecast by Region (2026-2031)
12.1.2 Global Smart Pills and Drugs Delivery System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Smart Pills and Drugs Delivery System Forecast by Type (2026-2031)
12.7 Global Smart Pills and Drugs Delivery System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.1.3 BD Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.2.3 Abbott Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 HCmed Innovations
13.3.1 HCmed Innovations Company Information
13.3.2 HCmed Innovations Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.3.3 HCmed Innovations Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 HCmed Innovations Main Business Overview
13.3.5 HCmed Innovations Latest Developments
13.4 Adherium
13.4.1 Adherium Company Information
13.4.2 Adherium Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.4.3 Adherium Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Adherium Main Business Overview
13.4.5 Adherium Latest Developments
13.5 BIOCORP
13.5.1 BIOCORP Company Information
13.5.2 BIOCORP Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.5.3 BIOCORP Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BIOCORP Main Business Overview
13.5.5 BIOCORP Latest Developments
13.6 Medtronic
13.6.1 Medtronic Company Information
13.6.2 Medtronic Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.6.3 Medtronic Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Medtronic Main Business Overview
13.6.5 Medtronic Latest Developments
13.7 Novartis AG
13.7.1 Novartis AG Company Information
13.7.2 Novartis AG Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.7.3 Novartis AG Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novartis AG Main Business Overview
13.7.5 Novartis AG Latest Developments
13.8 Novo Nordisk A/S
13.8.1 Novo Nordisk A/S Company Information
13.8.2 Novo Nordisk A/S Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.8.3 Novo Nordisk A/S Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Novo Nordisk A/S Main Business Overview
13.8.5 Novo Nordisk A/S Latest Developments
13.9 Amiko Digital Health
13.9.1 Amiko Digital Health Company Information
13.9.2 Amiko Digital Health Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.9.3 Amiko Digital Health Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Amiko Digital Health Main Business Overview
13.9.5 Amiko Digital Health Latest Developments
13.10 Boston Scientific Corporation
13.10.1 Boston Scientific Corporation Company Information
13.10.2 Boston Scientific Corporation Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.10.3 Boston Scientific Corporation Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Boston Scientific Corporation Main Business Overview
13.10.5 Boston Scientific Corporation Latest Developments
13.11 CeQur Simplicity
13.11.1 CeQur Simplicity Company Information
13.11.2 CeQur Simplicity Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.11.3 CeQur Simplicity Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 CeQur Simplicity Main Business Overview
13.11.5 CeQur Simplicity Latest Developments
13.12 Microchip Technology
13.12.1 Microchip Technology Company Information
13.12.2 Microchip Technology Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.12.3 Microchip Technology Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Microchip Technology Main Business Overview
13.12.5 Microchip Technology Latest Developments
13.13 FUJIFILM Holdings Corporation
13.13.1 FUJIFILM Holdings Corporation Company Information
13.13.2 FUJIFILM Holdings Corporation Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.13.3 FUJIFILM Holdings Corporation Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 FUJIFILM Holdings Corporation Main Business Overview
13.13.5 FUJIFILM Holdings Corporation Latest Developments
13.14 E3D Elcam Drug Delivery Devices
13.14.1 E3D Elcam Drug Delivery Devices Company Information
13.14.2 E3D Elcam Drug Delivery Devices Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.14.3 E3D Elcam Drug Delivery Devices Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 E3D Elcam Drug Delivery Devices Main Business Overview
13.14.5 E3D Elcam Drug Delivery Devices Latest Developments
13.15 Koninklijke Philips N.V
13.15.1 Koninklijke Philips N.V Company Information
13.15.2 Koninklijke Philips N.V Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.15.3 Koninklijke Philips N.V Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Koninklijke Philips N.V Main Business Overview
13.15.5 Koninklijke Philips N.V Latest Developments
13.16 H&T Presspart Manufacturing
13.16.1 H&T Presspart Manufacturing Company Information
13.16.2 H&T Presspart Manufacturing Smart Pills and Drugs Delivery System Product Portfolios and Specifications
13.16.3 H&T Presspart Manufacturing Smart Pills and Drugs Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 H&T Presspart Manufacturing Main Business Overview
13.16.5 H&T Presspart Manufacturing Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
